Pro Vise Management Group, LLC Sanofi Transaction History

Pro Vise Management Group, LLC

  • $1.25 Billion
  • Q3 2024

A detailed history of Pro Vise Management Group, LLC transactions in Sanofi stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 186,694 shares of SNY stock, worth $9.96 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
186,694
Previous 176,728 5.64%
Holding current value
$9.96 Million
Previous $8.57 Million 25.54%
% of portfolio
0.86%
Previous 0.73%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$48.54 - $58.53 $483,749 - $583,309
9,966 Added 5.64%
186,694 $10.8 Million
Q2 2024

Aug 12, 2024
BUY
$45.39 - $50.36 $250,053 - $277,433
5,509 Added 3.22%
176,728 $8.57 Million
Q1 2024

May 09, 2024
BUY
$45.75 - $52.48 $466,055 - $534,613
10,187 Added 6.33%
171,219 $8.32 Million
Q4 2023

Feb 09, 2024
BUY
$43.13 - $54.79 $368,934 - $468,673
8,554 Added 5.61%
161,032 $8.01 Million
Q3 2023

Nov 08, 2023
BUY
$50.95 - $55.2 $180,974 - $196,070
3,552 Added 2.39%
152,478 $8.18 Million
Q2 2023

Aug 24, 2023
SELL
$50.45 - $57.18 $103,069 - $116,818
-2,043 Reduced 1.35%
148,926 $8.03 Million
Q1 2023

May 05, 2023
SELL
$45.86 - $54.45 $672,399 - $798,345
-14,662 Reduced 8.85%
150,969 $8.22 Million
Q4 2022

Feb 09, 2023
SELL
$38.86 - $48.55 $487,304 - $608,817
-12,540 Reduced 7.04%
165,631 $8.02 Million
Q3 2022

Nov 09, 2022
BUY
$37.22 - $100.5 $35,954 - $97,083
966 Added 0.55%
178,171 $6.77 Million
Q2 2022

Aug 08, 2022
BUY
$48.99 - $57.46 $159,168 - $186,687
3,249 Added 1.87%
177,205 $8.87 Million
Q1 2022

Apr 27, 2022
BUY
$48.48 - $53.65 $115,479 - $127,794
2,382 Added 1.39%
173,956 $8.93 Million
Q4 2021

Jan 18, 2022
BUY
$47.07 - $52.35 $435,726 - $484,603
9,257 Added 5.7%
171,574 $8.6 Million
Q3 2021

Oct 20, 2021
BUY
$47.89 - $53.12 $425,502 - $471,971
8,885 Added 5.79%
162,317 $7.83 Million
Q2 2021

Aug 06, 2021
SELL
$49.36 - $54.25 $151,535 - $166,547
-3,070 Reduced 1.96%
153,432 $8.08 Million
Q1 2021

Apr 22, 2021
SELL
$45.46 - $50.51 $56,779 - $63,086
-1,249 Reduced 0.79%
156,502 $7.74 Million
Q4 2020

Jan 19, 2021
SELL
$45.3 - $51.62 $9,513 - $10,840
-210 Reduced 0.13%
157,751 $7.67 Million
Q3 2020

Oct 26, 2020
SELL
$49.47 - $53.77 $24,339 - $26,454
-492 Reduced 0.31%
157,961 $7.93 Million
Q2 2020

Aug 07, 2020
SELL
$42.91 - $52.5 $371,557 - $454,597
-8,659 Reduced 5.18%
158,453 $8.09 Million
Q1 2020

May 07, 2020
SELL
$38.02 - $51.66 $202,494 - $275,141
-5,326 Reduced 3.09%
167,112 $7.31 Million
Q4 2019

Feb 11, 2020
BUY
$44.25 - $50.86 $190,850 - $219,359
4,313 Added 2.57%
172,438 $8.66 Million
Q3 2019

Nov 13, 2019
BUY
$40.34 - $46.64 $1.8 Million - $2.08 Million
44,572 Added 36.08%
168,125 $7.79 Million
Q2 2019

Aug 09, 2019
BUY
$40.43 - $44.3 $171,504 - $187,920
4,242 Added 3.56%
123,553 $5.35 Million
Q1 2019

May 13, 2019
SELL
$40.83 - $45.43 $607,142 - $675,544
-14,870 Reduced 11.08%
119,311 $5.28 Million
Q4 2018

Feb 13, 2019
SELL
$41.48 - $45.59 $290,857 - $319,677
-7,012 Reduced 4.97%
134,181 $5.83 Million
Q3 2018

Nov 05, 2018
SELL
$40.0 - $44.84 $82,680 - $92,684
-2,067 Reduced 1.44%
141,193 $6.31 Million
Q2 2018

Aug 13, 2018
SELL
$37.63 - $41.22 $16,369 - $17,930
-435 Reduced 0.3%
143,260 $12.9 Million
Q1 2018

May 09, 2018
BUY
$38.98 - $45.76 $364,268 - $427,627
9,345 Added 6.96%
143,695 $5.76 Million
Q4 2017

Feb 07, 2018
SELL
$42.86 - $50.61 $507,376 - $599,121
-11,838 Reduced 8.1%
134,350 $5.78 Million
Q3 2017

Nov 08, 2017
BUY
$47.04 - $50.34 $6.88 Million - $7.36 Million
146,188
146,188 $7.28 Million

Others Institutions Holding SNY

# of Institutions
807
Shares Held
267M
Call Options Held
2M
Put Options Held
1.9M
View Full List

About Sanofi

SNY Quotes by TradingView
  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $134B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email